Artificial mechanical hearts and ventricular assist devices

Tessa M.F. Watt, Francis D. Pagani

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations


Mechanical circulatory support (MCS) with durable ventricular assist devices (VADs) has become an accepted therapy for advanced heart failure that is refractory to medical management. There have been many advances in the landscape of VAD technology over the past two decades. This chapter outlines clinically available solutions, clinical trials and experimental treatments, and preclinical technologies that are in development. These notable advancements in device designs have been associated with significant improvements in patient outcomes. In order for the field of MCS to evolve and become accessible to a population of patients with less-advanced heart failure, continued progress is needed to reduce the current burden of major adverse events. It is likely that in the next decade a majority of these hurdles can be overcome and that VAD therapy can expand to a broader population of patients with advanced heart failure.

Original languageEnglish (US)
Title of host publicationEmerging Technologies for Heart Diseases
Subtitle of host publicationVolume 1: Treatments for Heart Failure and Valvular Disorders
Number of pages16
ISBN (Electronic)9780128137062
StatePublished - Jan 1 2020
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2020 Elsevier Inc. All rights reserved.


  • Biventricular support
  • Continuous-flow pump
  • Heart failure
  • Mechanical circulatory support
  • Ventricular assist device


Dive into the research topics of 'Artificial mechanical hearts and ventricular assist devices'. Together they form a unique fingerprint.

Cite this